2018
DOI: 10.1016/j.echo.2017.09.014
|View full text |Cite
|
Sign up to set email alerts
|

Left Atrial Appendage Occlusion/Exclusion: Procedural Image Guidance with Transesophageal Echocardiography

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
48
0
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 55 publications
(53 citation statements)
references
References 35 publications
0
48
0
1
Order By: Relevance
“…However, full assessment of the morphology and size of the LAA before surgery can improve the success rate and effectiveness of such occlusion. [12][13][14] In this study, transesophageal echocardiography (TEE), LAA angiography, cardiac computed tomography angiography (CTA), and threedimensional (3D) reconstruction model of the heart based on CTA were used to fully evaluate the morphology and structure of the LAA to improve the success rate and effect of LAA occlusion.…”
Section: Introductionmentioning
confidence: 99%
“…However, full assessment of the morphology and size of the LAA before surgery can improve the success rate and effectiveness of such occlusion. [12][13][14] In this study, transesophageal echocardiography (TEE), LAA angiography, cardiac computed tomography angiography (CTA), and threedimensional (3D) reconstruction model of the heart based on CTA were used to fully evaluate the morphology and structure of the LAA to improve the success rate and effect of LAA occlusion.…”
Section: Introductionmentioning
confidence: 99%
“…Precise delineation of the LAA anatomy is essential for appropriate patient selection and intraprocedural guidance. In this setting, two‐dimensional (2D) and three‐dimensional (3D) transesophageal echocardiography (TEE) has been the primary imaging modality in addition to computed tomography …”
mentioning
confidence: 99%
“…In this setting, two-dimensional (2D) and three-dimensional (3D) transesophageal echocardiography (TEE) has been the primary imaging modality in addition to computed tomography. [1][2][3] Recent improvements in 3D TEE postprocessing rendering techniques referred to as TrueVue (Philips Medical Systems). It allows for novel photorealistic imaging of cardiac structures including left atrial appendage (LAA) and its closure devices.…”
mentioning
confidence: 99%
“…Other LAA occlusion devices are currently in clinical trials in the US, such as the Amulet device (St. Jude Medical, Minneapolis, MN). 1,3 The Lariat device (Sentre-HEART, Palo Alto, CA) is also currently being used in clinical practice, but differs from the occlusion devices in that it is an exclusion device which is used to ligate the LAA. 3 The purpose of all these devices is to close off the LAA so that a LAA thrombus cannot embolize, thus saving the patient from a detrimental outcome, such as a stroke.…”
mentioning
confidence: 99%
“…It is always important to make sure a pericardial effusion is not developing during the procedure, as this would suggest a perforation. 3 After device implantation, the patients will receive additional TEEs to confirm the device is still in good position and stable, without a significant residual leak, and without any thrombus formation on the device. 3 Ideally, AFib patients with LAA occlusion can eventually discontinue anticoagulant use, dramatically reducing their morbidity and mortality and improving quality of life.…”
mentioning
confidence: 99%